Clinical Trials Browser

Phase 2/3 × OTHER × CNS × Clear all

NCT03970447 2026-04-08

GBM AGILE

Phase 2/3 Recruiting

Glioblastoma, Recurrence

NCT07440290 2026-02-27

DETERMINE

Phase 2/3 Not yet recruiting

CNSEndocrineGastrointestinalGynecologicHead & NeckLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Glioma, Histiocytosis, Langerhans-Cell, Laryngeal Neoplasms, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

NCT05669820 2026-01-09

AFGB2

Phase 2/3 Recruiting

Glioblastoma

NCT02066220 2025-12-04

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

Phase 2/3 Active not recruiting

Brain Neoplasms, Medulloblastoma, Neuroectodermal Tumors, Primitive

NCT05768178 2025-11-24

DETERMINE

Phase 2/3 Recruiting

CNSDermatologicEndocrineGastrointestinalGynecologicHead & NeckMyeloidOther hematologic neoplasmPlasma cellThoracic

Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Glioma, Laryngeal Neoplasms, Melanoma, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Ovarian Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms, Erdheim-Chester Disease, Thyroid Carcinoma, Anaplastic

NCT05770037 2025-11-24

DETERMINE

Phase 2/3 Recruiting

CNSGenitourinaryLymphoidOther hematologic neoplasm

Carcinoma, Renal Cell, Lymphoma, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neuroblastoma, Lymphoma, Large-Cell, Anaplastic, Hematologic Neoplasms

NCT05770544 2025-11-24

DETERMINE

Phase 2/3 Recruiting

CNSDermatologicLymphoidOther hematologic neoplasm

Brain Neoplasms, Glioma, Lymphoproliferative Disorders, Melanoma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Hematologic Neoplasms

NCT06988475 2025-11-24

DETERMINE

Phase 2/3 Recruiting

CNSGastrointestinalOther hematologic neoplasmSarcoma

Glioma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neuroblastoma, Sarcoma, Stomach Neoplasms, Hematologic Neoplasms

NCT05807893 2024-11-13

SUPER BRAIN

Phase 2/3 Completed

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03548571 2024-04-03

DEN-STEM

Phase 2/3 Recruiting

Glioblastoma

NCT05096468 2023-07-06

Esketamine Combined With Pregabalin on Acute Postoperative Pain in Patients Undergoing Resection of Spinal Neoplasms.

Phase 2/3 Completed

Pain, Postoperative, Spinal Cord Neoplasms

NCT02879682 2023-06-01

Motorstim

Phase 2/3 Completed

Brain Neoplasms, Glioma

NCT02448992 2023-05-01

Hippocampal-Sparing Prophylactic Cranial Irradiation in Pathologically Nodal Positive Non-Small-Cell Lung Cancer

Phase 2/3 Recruiting

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03534050 2023-05-01

Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Radiotherapy

Phase 2/3 Recruiting

Glioma

NCT00442533 2023-04-03

Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors

Phase 2/3 Completed

CNSEndocrineNET

Carcinoid Tumor, Paraganglioma, Pheochromocytoma, Somatostatinoma, Neuroendocrine Tumors

NCT02881957 2022-06-15

Hypovitaminosis D in Neurocritical Patients

Phase 2/3 Completed

274 enrolled 16 charts

Brain Neoplasms, Intracranial Aneurysm, Craniocerebral Trauma, Meningitis, Seizures, Spinal Cord Injuries, Vitamin D Deficiency, Critical Illness, Intracranial Hemorrhages, Stroke

NCT03025893 2021-04-19

STELLAR

Phase 2/3 Unknown

Brain Neoplasms, Glioblastoma

NCT02678975 2021-03-18

Disulfiram in Recurrent Glioblastoma

Phase 2/3 Completed

Glioblastoma, Glioma

NCT02256124 2020-04-14

NF1-EXCEL

Phase 2/3 Terminated

Neurofibromatosis 1

NCT04105374 2020-03-24

Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma

Phase 2/3 Withdrawn

Astrocytoma, Glioblastoma, Oligodendroglioma

NCT00539500 2019-07-26

Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma

Phase 2/3 Terminated

3 enrolled 4 charts

Neuroblastoma

NCT00749723 2018-07-20

HIT-REZ-2005

Phase 2/3 Completed

Brain Neoplasms, Ependymoma, Medulloblastoma, Recurrence

NCT01759810 2017-10-12

Proteome-based Personalized Immunotherapy of Glioblastoma

Phase 2/3 Unknown

Glioblastoma

NCT01782274 2017-10-12

Proteome-based Immunotherapy of Brain Metastases From Breast Cancer

Phase 2/3 Unknown

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis

NCT01782287 2017-10-12

Proteome-based Immunotherapy of Lung Cancer Brain Metastases

Phase 2/3 Unknown

Brain Neoplasms, Lung Neoplasms, Neoplasm Metastasis

NCT00002533 2016-12-15

Fluconazole in Preventing Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer

Phase 2/3 Completed

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Infections, Esthesioneuroblastoma, Olfactory

NCT01961934 2016-09-28

C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression

Phase 2/3 Withdrawn

Glioblastoma, Glioma, Recurrence

NCT00123760 2016-02-25

Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer

Phase 2/3 Completed

10,838 enrolled

CNSGastrointestinalHead & NeckLymphoidThoracic

Brain Neoplasms, Lung Neoplasms, Lymphoma, Thyroid Neoplasms, Colorectal Neoplasms

NCT02338011 2015-01-26

EGFR

Phase 2/3 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT01813240 2013-03-18

Prevention of Imminent Paralysis Following Spinal Cord Trauma or Ischemia by Minocycline: A Multi-center Study in Israel With IDF Primary Care Involvement

Phase 2/3 Unknown

cyclopia sequence, Spinal Cord Neoplasms

NCT00921037 2011-07-13

First Clinical Study of Erbium - Yttrium Aluminium Garnet (YAG) Laser Vaporization of Cutaneous Neurofibromas

Phase 2/3 Unknown

Neurofibromatosis 1

NCT01308632 2011-03-04

Metronomic Temozolamide in Patients With Recurrent Glioblastoma

Phase 2/3 Unknown

Glioblastoma